Keratotic melanocytic nevus: A clinicopathologic and immunohistochemical study

Journal of Cutaneous Pathology

Volumn 27, Issue 7, 2000, Pages 344-350

  Horenstein, Marcelo G ^a,b   Prieto, Victor G ^a,c   Burchette Jr , James L ^a   Shea, Christopher R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CELL PROLIFERATION; CLINICAL TRIAL; EPIDERMIS HYPERPLASIA; FEMALE; FIBROMA; HAIR FOLLICLE; HEAD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; LIMB; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; NECK; NEVUS; PAPILLOMATOSIS; PROSPECTIVE STUDY; SEBORRHEIC KERATOSIS; TRUNK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KERATOSIS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEVUS, PIGMENTED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN NEOPLASMS;

EID: 0033937694     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2000.027007344.x     Document Type: Article

References (23)

1. 1. Pack GT, Davis J. The pigmented mole. Postgrad Med 1960; 27: 370.
2. 2. Bentley-Phillips CB, Marks R. The epidermal component of melanocytic naevi. J Cutan Pathol 1976; 3: 190.
3. 3. Gurbuz O, Hurwitz RM. Keratotic melanocytic nevus. Int J Dermatol 1990; 29: 713.
4. 4. Elder D, Elenitsas R. Benign pigmented lesions and malignant melanoma. In: Elder D, ed. Lever's Histopathology of the skin. 7th ed. Philadelphia: Lippincott-Raven Publishers; 1997: 625.
5. 5. Freeman RG, Knox JM. Epidermal cysts associated with pigmented nevi. Arch Dermatol 1962; 85: 590.
6. 6. Morgan MB, Raley BA, Vannarath RL, Lightfoot SL, Everett MA. Papillomatous melanocytic nevi: an estrogen related phenomenon. J Cutan Pathol 1995; 22: 446.
7. 7. McKee PH. Pathology of the skin with clinical correlations. 2nd ed. Chicago: Mosby-Wolfe, 1996.
8. 8. Hurwitz RM, Hood A. Atlas of dermatopathology 1st ed. Stamford: Appleton & Lange, 1998.
9. 9. Rhodes AR, Silverman RA, Harrist TJ, Melski JW. A histologic comparison of congenital and acquired nevomelanocytic nevi. Arch Dermatol 1985; 121: 1266.
10. 10. Shea CR, Vollmer RT, Prieto VG. Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol 1999; 30: 500.
11. 11. Undeutsch W, Schneider W. New development of sebaceous glands over histiocytomas. Hautarzt 1970; 21: 454.
12. 12. Busam KJ, Kiehn TE, Salob SP, Myskowski PL. Histologic reactions to cutaneous infections by Mycobacterium haemophilum. Am J Surg Pathol 1999; 23: 1379.
13. 13. Schmoeckel C. Classification of melanocytic nevi: do nodular and flat nevi develop differently? Am J Dermatopathol 1997; 19: 31.
14. 14. Blessing K, Evans AT, al-Nafussi A. Verrucous naevoid and keratotic malignant melanoma: a clinico-pathological study of 20 cases. Histopathology 1993; 23: 453.
15. 15. Wong TY, Suster S, Duncan LM, Mihm MC, Jr. Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus. Hum Pathol 1995; 26: 171.
16. 16. Duchrow M, Gerdes J, Schluter C. The proliferation associated Ki-67 protein: definition in molecular terms. Cell Prolif 1994; 27: 235.
17. 17. Barrett TL, Smith KJ, Williams J, Corner SW, Hodge JJ, Skelton HG. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus. Mod Pathol 1999; 12: 450.
18. 18. Hartschuh W, Schulz T. Immunohistochemical investigation of the different developmental stages of trichofolliculoma with special reference to the Merkel cell. Am J Dermatopathol 1999; 21: 8.
19. 19. Nanney LB, McKanna JA, Stoscheck CM, Carpenter G, King LE. Visualization of epidermal growth factor receptors in human epidermis. J Invest Dermatol 1984; 82: 165.
20. 20. Groves RW, Allen MH, MacDonald DM. Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumours. J Cutan Pathol 1992; 19: 66.
21. 21. Higashiyama M, Hashimoto K, Matsumoto K, Yoshikawa K. Differential expression of transforming growth factor-alpha (TGF-alpha) and EGF receptor in transitional area of psoriatic epidermis. J Dermatol Sci 1994; 7: 45.
22. 22. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997; 3: 614.
23. 23. Wrone-Smith T, Bergstrom J, Quevedo ME, Reddy V, Gutierrez-Steil C, Nickoloff BJ. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions. J Dermatol Sci 1999; 19: 53.